Purchase by Erdtmann Rainer M of 2400 shares of Biomea Fusion
BMEA Stock | USD 7.27 0.03 0.41% |
About 53% of Biomea Fusion's investor base is interested to short. The analysis of the overall investor sentiment regarding Biomea Fusion suggests that many traders are impartial. The current market sentiment, together with Biomea Fusion's historical and current headlines, can help investors time the market. In addition, many technical investors use Biomea Fusion stock news signals to limit their universe of possible portfolio assets.
Biomea |
Filed transaction by Biomea Fusion Inc director. General open market or private purchase of non-derivative or derivative security
Read at macroaxis.com
Cash Flow Correlation
Biomea Fusion's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Biomea Fusion's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Biomea Fusion Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Biomea Fusion can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Biomea Fusion Fundamental Analysis
We analyze Biomea Fusion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biomea Fusion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biomea Fusion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Biomea Fusion is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Biomea Fusion Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biomea Fusion stock to make a market-neutral strategy. Peer analysis of Biomea Fusion could also be used in its relative valuation, which is a method of valuing Biomea Fusion by comparing valuation metrics with similar companies.
Peers
Biomea Fusion Related Equities
DSGN | Design Therapeutics | 4.67 | ||||
IKNA | Ikena Oncology | 1.16 | ||||
HOWL | Werewolf Therapeutics | 2.00 | ||||
CGEM | Cullinan Oncology | 2.08 | ||||
EWTX | Edgewise Therapeutics | 4.42 |
Complementary Tools for Biomea Stock analysis
When running Biomea Fusion's price analysis, check to measure Biomea Fusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomea Fusion is operating at the current time. Most of Biomea Fusion's value examination focuses on studying past and present price action to predict the probability of Biomea Fusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomea Fusion's price. Additionally, you may evaluate how the addition of Biomea Fusion to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Stocks Directory Find actively traded stocks across global markets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |